406 related articles for article (PubMed ID: 32169891)
21. Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.
Li DY; Lin FF; Li GP; Zeng FC
Kaohsiung J Med Sci; 2021 Nov; 37(11):973-982. PubMed ID: 34337864
[TBL] [Abstract][Full Text] [Related]
22. CLEC12B suppresses lung cancer progression by inducing SHP-1 expression and inactivating the PI3K/AKT signaling pathway.
Chi D; Wang D; Zhang M; Ma H; Chen F; Sun Y
Exp Cell Res; 2021 Dec; 409(2):112914. PubMed ID: 34780782
[TBL] [Abstract][Full Text] [Related]
23. TAGLN2 Promotes the Proliferation, Migration, Invasion, and EMT of Clear Cell Renal Cell Carcinoma Through the PI3K/Akt Signaling Pathway.
He Y; Zhang B; Han D; Du Y; Zhang X; Wang H; Yue Z; Shang P
Biochem Genet; 2023 Aug; 61(4):1265-1281. PubMed ID: 36547768
[TBL] [Abstract][Full Text] [Related]
24.
Pan H; Hong Y; Yu B; Li L; Zhang X
Cancer Biother Radiopharm; 2019 Jun; 34(5):334-341. PubMed ID: 30844301
[No Abstract] [Full Text] [Related]
25. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.
Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730
[TBL] [Abstract][Full Text] [Related]
27. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
Huang JL; Liao Y; Qiu MX; Li J; An Y
Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA‑663 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells by directly targeting PAK4.
Liu Y; Jiao D; Tian Z
Mol Med Rep; 2019 Jan; 19(1):711-718. PubMed ID: 30431118
[TBL] [Abstract][Full Text] [Related]
30. KIR2DL4 promotes the proliferation of RCC cell associated with PI3K/Akt signaling activation.
Ding XF; Chen J; Ma HL; Liang Y; Wang YF; Zhang HT; Li X; Chen G
Life Sci; 2022 Mar; 293():120320. PubMed ID: 35063466
[TBL] [Abstract][Full Text] [Related]
31. SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p.
Yu H; Liu J; Zhang Z; Zhu Y; Bi J; Kong C
J Cell Mol Med; 2021 May; 25(10):4696-4708. PubMed ID: 33787057
[TBL] [Abstract][Full Text] [Related]
32. Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis.
Liu G; Zhou J; Piao Y; Zhao X; Zuo Y; Ji Z
Aging (Albany NY); 2020 Jun; 12(12):11530-11549. PubMed ID: 32541093
[TBL] [Abstract][Full Text] [Related]
33. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.
Yang Q; Ji G; Li J
Cancer Biol Ther; 2020; 21(3):278-291. PubMed ID: 31696760
[TBL] [Abstract][Full Text] [Related]
34. Network Analysis and Basic Experiments on the Inhibition of Renal Cancer Proliferation and Migration by Alpinetin through PI3K/AKT/ mTOR Pathway.
Guo Y; Jiang L; Luo S; Hu D; Zhao X; Zhao G; Tang W
Curr Mol Med; 2024; 24(1):134-144. PubMed ID: 37221689
[TBL] [Abstract][Full Text] [Related]
35. Dicer suppresses MMP-2-mediated invasion and VEGFA-induced angiogenesis and serves as a promising prognostic biomarker in human clear cell renal cell carcinoma.
Chen YS; Meng F; Li HL; Liu QH; Hou PF; Bai J; Zheng JN
Oncotarget; 2016 Dec; 7(51):84299-84313. PubMed ID: 27732931
[TBL] [Abstract][Full Text] [Related]
36. Capn4 contributes to tumor invasion and metastasis in clear cell renal cell carcinoma cells via modulating talin-focal adhesion kinase signaling pathway.
Zhuang Q; Luo W; Zhang M; Fan M; Lu H; Xu R; He X
Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):465-472. PubMed ID: 29648579
[TBL] [Abstract][Full Text] [Related]
37. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
[TBL] [Abstract][Full Text] [Related]
38. PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation.
Tao T; Yang X; Zheng J; Feng D; Qin Q; Shi X; Wang Q; Zhao C; Peng Z; Liu H; Jiang WG; He J
Oncogene; 2017 Nov; 36(44):6119-6131. PubMed ID: 28692056
[TBL] [Abstract][Full Text] [Related]
39. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
[TBL] [Abstract][Full Text] [Related]
40. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
Lin H; Zeng W; Lei Y; Chen D; Nie Z
Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
